newsfilter
← Latest News
GlobeNewswire·

Humacyte Announces Fourth Quarter and Year End 2025 Financial Results and Provides Business Update

- Total revenues from sales and research collaborations were $0.5 million for fourth quarter and $2.0 million for full year - - Purchase commitment received for a minimum of $1.475 million for a clinical evaluation